| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 01/05/2005 | EP1492536A1 4-(n-phenylamino)-quinazolines / quinolines as tyrosine kinase inhibitors |
| 01/05/2005 | EP1492532A1 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations |
| 01/05/2005 | EP1282414B1 Felbamate derived compounds for treating neuropathic pain |
| 01/05/2005 | EP1248630B9 Use of a dermatological composition containing oligosaccharides for the treatment of skin diseases |
| 01/05/2005 | EP1178801B1 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 01/05/2005 | EP1073413B1 Methods and compositions for stabilizing acetylcholine compositions |
| 01/05/2005 | DE19957065B4 Screening-Verfahren für Arzneistoffe A screening method for drugs |
| 01/05/2005 | CN1561393A Inhibitors of glycogen synthase kinase-3 (GSK-3) for treating glaucoma |
| 01/05/2005 | CN1561344A Angiogenesis-inhibitory tripeptides, compositions and their methods of use |
| 01/05/2005 | CN1561226A Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 01/05/2005 | CN1561223A New drug |
| 01/05/2005 | CN1561220A Method for the treatment of inflammation |
| 01/05/2005 | CN1561216A Novel compounds |
| 01/05/2005 | CN1561215A Salts of substituted 1, 2, 3, 4-tetrahydroquinoline-2-carboxylic acid compounds used as nmda antagonist |
| 01/05/2005 | CN1561212A Benzimidazolidinone derivatives as muscarinic agents |
| 01/05/2005 | CN1561211A Nociceptin analogs |
| 01/05/2005 | CN1561199A Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 01/05/2005 | CN1560041A Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 01/05/2005 | CN1559594A Chinese medicine for treating epicophosis, sonitus |
| 01/05/2005 | CN1559579A Preparation of medicine for treating herpes simplex keratitis |
| 01/05/2005 | CN1559401A Therapeutic use and compositions involving isoflavones |
| 01/05/2005 | CN1183136C Indoloquinazolinones |
| 01/04/2005 | US6838466 Compounds for the treatment of inflammatory disorders |
| 01/04/2005 | US6838456 Condensed pyridoindole derivatives |
| 01/04/2005 | US6838454 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 01/04/2005 | US6838453 Therapy for osteoporosis |
| 01/04/2005 | US6838449 Ophthalmic compositions containing galactomannan polymers and borate |
| 01/04/2005 | US6838444 Using nucleic acid; repair interior ear hair |
| 01/04/2005 | US6838442 Administering to said subject a jointly effective amount of a glucose reabsorption inhibitor; administering jointly effective amount of an retinoid-X receptor modulator for therapy of diabetes or Syndrome X |
| 01/04/2005 | US6838093 System for osmotic delivery of pharmaceutically active agents |
| 12/30/2004 | US20040268425 use to treat glycosaminoglycan associated pathologies such as eye disorders or tumors; sialated and pegylated forms of a recombinant sHASEGP to enhance stability and serum pharmacokinetics over naturally occurring slaughterhouse enzymes; transgenic animals; dosage forms |
| 12/30/2004 | US20040267025 Compounds for the treatment of metabolic disorders |
| 12/30/2004 | US20040267016 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 12/30/2004 | US20040267010 For therapy of central nervous system disorders |
| 12/30/2004 | US20040266842 Thiazolyl substituted triazoles as alk5 inhibitors |
| 12/30/2004 | US20040266841 Thiazole derivatives having cb1-antagonistic, agonistic or partial agonistic activity |
| 12/30/2004 | US20040266826 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 12/30/2004 | US20040266793 Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)one derivatives for neurodegenerative disorders |
| 12/30/2004 | US20040266780 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 12/30/2004 | US20040266770 treating diseases that are triggered by persistent angiogenesis; inhibition of the VEGF receptor |
| 12/30/2004 | US20040266764 Hydroxamic acid derivatives |
| 12/30/2004 | US20040266750 Beta-lactamyl vasopressin v1aantagonists |
| 12/30/2004 | US20040266725 Polysaccharide-containing compositions and use thereof |
| 12/30/2004 | US20040266702 Topical treatment or prevention of ocular infections |
| 12/30/2004 | US20040266686 Administering endothelial growth factor antagonist; wound healing agents |
| 12/30/2004 | US20040265968 Tissue plasminogen activator-like protease |
| 12/30/2004 | US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery |
| 12/30/2004 | US20040265317 Methods and compositions useful for inhibition of angiogenesis |
| 12/30/2004 | US20040261190 Hydrazono-malonitriles |
| 12/29/2004 | WO2004113300A1 Novel tricyclic heterocycle compound |
| 12/29/2004 | WO2004112830A2 Clostridial toxins for treating eye disorders |
| 12/29/2004 | WO2004112811A1 Eye-rinse solution made of grape juice |
| 12/29/2004 | WO2004112789A1 Ophthalmic composition |
| 12/29/2004 | WO2004112748A2 Rate controlled release of a pharmaceutical agent in a biodegradable device |
| 12/29/2004 | WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 12/29/2004 | WO2002043648A3 Compounds active at the glucocorticoid receptor ii |
| 12/29/2004 | WO2000061774A3 Bone morphogenic proteins |
| 12/29/2004 | EP1491632A2 Anti-alphavbeta3 humanized monoclonal antibodies |
| 12/29/2004 | EP1491537A1 Hydroxymorpholinone derivative and medicinal use thereof |
| 12/29/2004 | EP1491531A1 (1-indanone)-(1,2,3,6-tetrahydropyridine) derivative |
| 12/29/2004 | EP1491205A1 Remedy for hypermyotonia |
| 12/29/2004 | EP1491203A1 Compositions for treating and/or preventing pollenosis |
| 12/29/2004 | EP1491194A1 Vdac regulator |
| 12/29/2004 | EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 12/29/2004 | EP1490406A1 Costimulatory molecule and its use |
| 12/29/2004 | EP1490395A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 12/29/2004 | EP1490366A1 Novel alkoxypyridine-derivatives |
| 12/29/2004 | EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors |
| 12/29/2004 | EP1490341A1 Novel adamantane derivatives |
| 12/29/2004 | EP1490339A1 Novel chalcone derivatives and uses thereof |
| 12/29/2004 | EP1490338A1 Use of an alfa2-adrenoreceptor antagonist for cns-related diseases |
| 12/29/2004 | EP1490335A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/29/2004 | EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1490113A2 Raav vector compositions and methods for the treatment of choroidal neovascularization |
| 12/29/2004 | EP1490071A2 Theraputic methods and uses of sapogenins and their derivatives |
| 12/29/2004 | EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors |
| 12/29/2004 | EP1490064A1 Substituted pyridinones as modulators of p38 map kinase |
| 12/29/2004 | EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 12/29/2004 | EP1490055A1 Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension |
| 12/29/2004 | EP1489915A1 Treatment and prevention of inflammatory disorders |
| 12/29/2004 | EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 12/29/2004 | EP1244657B1 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 12/29/2004 | EP1233769A4 Novel compounds |
| 12/29/2004 | EP1226136B1 Tyrosine kinase inhibitors |
| 12/29/2004 | EP1225890B1 Rivastigmine for the treatment of ocular disorders |
| 12/29/2004 | EP1216234B1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 12/29/2004 | EP1196180B1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 12/29/2004 | EP1135123B1 Use of isatin derivatives as ion channel activating agents |
| 12/29/2004 | EP1123274B1 Substituted phenyl derivatives, their preparation and use |
| 12/29/2004 | EP1117643B1 New crystal modification n of torasemide |
| 12/29/2004 | EP1011728B1 Polypropylene containers for prostaglandin products |
| 12/29/2004 | EP0725635B1 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
| 12/29/2004 | CN1558907A Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists |
| 12/29/2004 | CN1558774A Angiotensin peptide-carrier conjugates and uses thereof |
| 12/29/2004 | CN1558751A Method and composition for dry eye treatment |
| 12/29/2004 | CN1557494A Preparation of microorganism resisting biological active component and its application |
| 12/29/2004 | CN1557349A Pill of antelope horn and pearl powder for treating eye disease |
| 12/29/2004 | CN1557345A Preparation and technique for making compound leech eye drip |
| 12/29/2004 | CN1557339A Preparation for preventing and treating tympanitis and dental caries |
| 12/29/2004 | CN1557317A Enoxacin Glyconate little volume injection and its preparation method |